Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Detecting Zika currently requires blood samples to be refrigerated and shipped to a laboratory for tests, delaying treatment and care to those in rural areas. Researchers from Washington University published a study in Advanced Biosystems that details a new technology capable of delivering Zika test results in minutes.
Researchers at the University of Illinois at Urbana-Champaign have utilized smartphone technology to develop a spectral transmission-reflectance-intensity (TRI) analyzer. The technology attaches to a smartphone and can analyze samples of blood, urine and saliva just as well as clinical instruments.
Cincinnati Children’s Hospital will move ahead with a $650 million expansion plan, including an eight-story patient tower, after receiving approval from the Cincinnati City Council.
New technologies are giving patients the ability to improve their own care while in the comfort of their own home. In an article by MIMS, three new technologies are showcased for their potential to one day be prescribed by physicians.
The idea of a national, single-payer healthcare system is as divisive as ever to people within the industry, according to a new survey from cloud-based researcher company Reaction Data.
Wearable fitness devices cling to wrists of many people who hope to improve health and fitness. Emory University in Atlanta utilized this readily available technology to see if these devices could get people moving.
When asked to identify what regulations are the most burdensome, physician practices pointed at the Merit-based Incentive Payment System (MIPS) being implemented as part of the Medicare Access and CHIP Reauthorization Act (MACRA).
The American Telemedicine Association will see a new CEO soon with Jon Linkous stepping down. After 24 years as the CEO, Linkous will be replaced by Sabrina Smith, MD, acting as interim CEO until a permanent replacement is found.
Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.